Latest California Healthline Stories
Blood Test That Screens for Cancer Raises Hopes, and Worries
The first of a new wave of cancer-detection blood tests likely saved Gilbert Milam Jr.’s life. But many cancer researchers, wary of overtesting, argue it’s premature to prescribe the Galleri test widely.
California Schools Start Hatching Heat Plans as the Planet Warms
State researchers offer recommendations on how schools can become more heat-resilient in the face of global warming. Proposed changes to state law could make it easier to build shade structures.
What Does a Chatbot Know About Eating Disorders? Users of a Help Line Are About to Find Out
The National Eating Disorders Association’s help line has seen demand climb to unsustainable levels since the beginning of the covid pandemic, with more people reporting severe mental health problems, the nonprofit says. But staffers worry this chatbot may make things worse.
KFF Health News' 'What the Health?': The Crisis Is Officially Ending, but Covid Confusion Lives On
The public health emergency declaration for covid-19 ends May 11, ushering in major changes in how Americans can access and pay for the vaccines, treatments, and tests particular to the culprit coronavirus. But not everyone will experience the same changes, creating a confusing patchwork of coverage — not unlike health coverage for other diseases. Meanwhile, outside advisers to the FDA formally recommended allowing a birth control pill to be sold without a prescription. If the FDA follows the recommendation, it would represent the first over-the-counter form of hormonal contraception. Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KFF Health News’ Julie Rovner to discuss these issues and more. Plus for “extra credit” the panelists suggest health policy stories they read this week they think you should read, too.
How One Patient’s Textured Hair Nearly Kept Her From a Needed EEG
An EEG can help diagnose conditions like epilepsy, sleep disorders, and brain tumors. But a design flaw and outdated Eurocentric practices make the test less effective on thicker, denser, and curly hair types, potentially excluding or deterring some people from getting screened.
Social Media Is Fueling Enthusiasm for New Weight Loss Drugs. Are Regulators Watching?
Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.
Feds Launch Criminal Investigation Into ‘AGGA’ Dental Device and Its Inventor
KFF Health News and CBS News recently reported that multiple lawsuits allege the device has led to grievous injuries to patients’ mouths, resulting in loss of teeth.
FDA Evaluates ‘Safety Concerns’ Over Dental Devices Featured in KHN-CBS Investigation
A KHN and CBS News investigation found that a dental appliance called the AGGA has been used by more than 10,000 patients, and multiple lawsuits allege it has caused grievous harm to patients.
A Secret Weapon in Preventing the Next Pandemic: Fruit Bats
New research links habitat destruction with the spillover of viruses from animals to humans.
Behavioral Telehealth Loses Momentum Without a Regulatory Boost
As flexible treatment options spurred by the covid pandemic wane, patients relying on medications classified as controlled substances worry that without action to extend the loosened rules, it’ll be harder to get their meds.